This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by McMaster University.
Recruitment status was:  Recruiting
St. Joseph's Healthcare Hamilton
Information provided by:
McMaster University Identifier:
First received: September 9, 2005
Last updated: January 23, 2006
Last verified: September 2005
This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.

Bleeding End Stage Renal Disease

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Retrospective
Official Title: Pilot Bleeding Study

Resource links provided by NLM:

Further study details as provided by McMaster University:

Estimated Enrollment: 490
Study Start Date: October 2003
Estimated Study Completion Date: April 2006

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient is undergoing hemodialysis

Exclusion Criteria:

  • This is an observational study. No exclusion criteria required.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00182117

Contact: Christian G Rabbat, MD 905-522-1155 ext 3542
Contact: Catherine M Clase, MD 905-522-1155 ext 6094

Canada, Ontario
St. Joseph's Healthcare Recruiting
Hamilton, Ontario, Canada, L8N 4A6
Contact: Christian G Rabbat, MD    905-522-1155 ext 6094   
Contact: Catherine M Clase, MD    905-522-1155 ext 6094   
Sponsors and Collaborators
Hamilton Health Sciences Corporation
St. Joseph's Healthcare Hamilton
Principal Investigator: Christian G Rabbat, MD Assistant Professor, Medicine
  More Information Identifier: NCT00182117     History of Changes
Other Study ID Numbers: Division of Nephrology Funds
Study First Received: September 9, 2005
Last Updated: January 23, 2006

Keywords provided by McMaster University:
end stage renal disease
antiplatelet therapy
anticoagulant therapy

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Pathologic Processes
Urologic Diseases
Renal Insufficiency processed this record on June 23, 2017